Optimization of individualized therapy with oral valproic acid in pediatric patients with epilepsy based on factors influencing blood concentrations
Frontiers in Pharmacology · 04.05.2026 · 17
DOI: 10.3389/fphar.2026.1793966 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 04.05.2026. Verfasst von Yinhui Qin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, He…. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Valproic acid (VPA) is widely used in pediatric epilepsy, but its blood concentrations vary considerably among pediatric patients with epilepsy. This study aimed to investigate the factors influencing VPA blood concentrations in this population.
Methods
This study included patients with epilepsy aged 0–18 years who were treated with VPA. Clinical data collected included age, gender, daily dose, biochemical parameters (liver and renal function), and electrolyte levels. VPA blood concentrations were measured by immunoassay. Correlation analyses and linear regressions were conducted to assess associations between clinical variables and VPA blood concentrations.
Results
The mean VPA blood concentration was 69.82 ± 25.22 μg/mL, and 70.06% of patients had blood concentrations within the therapeutic range. Daily dose was positively correlated with blood concentration ( r = 0.319, P < 0.001). Age was significantly associated with VPA blood concentration, with younger children (<6 years) receiving lower daily doses and exhibiting lower blood concentrations than older age groups (both P < 0.001). Creatinine and globulin levels were positively correlated with VPA blood concentrations (all P < 0.001), whereas alanine aminotransferase levels showed a negative correlation with blood concentrations ( P < 0.001). Notably, calcium and phosphorus levels were negatively correlated with VPA blood concentrations.
Conclusion
VPA blood concentrations in the study population were influenced by multiple factors, including daily dose, age, renal and hepatic function, and electrolyte status. Given the marked inter-individual variability, individualized treatment guided by therapeutic drug monitoring (TDM) is essential for optimizing dosing accuracy and therapeutic efficacy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, Henan, China.
- Shandong Academy of Chinese Medicine, Jinan, China.
- School of Medicine, Henan Engineering Research Center of Funiu Mountain's Medicinal Resources Utilization and Molecular Medicine, Pingdingshan University, Pingdingshan, China.
- Department of Pharmacy, Jinan Vocational College of Nursing, Jinan, China.
- Department of Pathology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, Henan, China.
Zitieren
APA
Qin, Y., Zhang, N., Zhang, P., Teng, Y., Xia, Z., Mao, Z., Wang, L., Yang, Y., & Niu, W. (2026). Optimization of individualized therapy with oral valproic acid in pediatric patients with epilepsy based on factors influencing blood concentrations. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1793966
Vancouver
Qin Y, Zhang N, Zhang P, Teng Y, Xia Z, Mao Z, et al. Optimization of individualized therapy with oral valproic acid in pediatric patients with epilepsy based on factors influencing blood concentrations. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1793966
BibTeX
@article{Qin2026,
author = {Qin, Yinhui and Zhang, Na and Zhang, Panpan and Teng, Yuetai and Xia, Zhengchao and Mao, Zhenkun and Wang, Lei and Yang, Yan and Niu, Weihong},
title = {Optimization of individualized therapy with oral valproic acid in pediatric patients with epilepsy based on factors influencing blood concentrations},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1793966}
}
EUVIMED